Research and Markets: Metastatic Melanoma Therapeutics Pipeline Report 2014 - 65 Companies & 50+ Drug Profiles

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/dg4fjh/metastatic) has announced the addition of the "Metastatic Melanoma - Pipeline Review, H2 2014" report to their offering.

This report provides comprehensive information on the therapeutic development for Metastatic Melanoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Melanoma and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Metastatic Melanoma Overview
  3. Therapeutics Development
  4. Metastatic Melanoma - Therapeutics under Development by Companies
  5. Metastatic Melanoma - Therapeutics under Investigation by Universities/Institutes
  6. Metastatic Melanoma - Pipeline Products Glance
  7. Metastatic Melanoma - Products under Development by Companies
  8. Metastatic Melanoma - Products under Investigation by Universities/Institutes
  9. Metastatic Melanoma - Companies Involved in Therapeutics Development
  10. Metastatic Melanoma - Therapeutics Assessment
  11. Drug Profiles
  12. Metastatic Melanoma - Recent Pipeline Updates
  13. Metastatic Melanoma - Dormant Projects
  14. Metastatic Melanoma - Discontinued Products
  15. Metastatic Melanoma - Product Development Milestones
  16. Appendix

For more information visit http://www.researchandmarkets.com/research/dg4fjh/metastatic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology